Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioMetas
Shanghai, Shanghai, Chinabiogeom.com ↗
- Ownership
- Private
- Employees
- ~150
- Development stage
- Preclinical
01
Overview
BioMetas is a leading China-based CRO/CDMO providing bespoke protein science, antibody design/production, DMPK/toxicity analysis, biosimilar development platforms (notably for PD‑1 antibodies), and comprehensive preclinical research services. The company enables biotech startups to efficiently progress drug candidates from concept through IND filing with global regulatory support. It has partnered with major industry players for AI-driven large molecule drug design and supports over 150 scientists across Shanghai HQ and Cambridge BD office. No proprietary clinical results disclosed as it is primarily a service provider.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Monoclonal antibodyAntibody-drug conjugateFusion proteinRecombinant proteinmRNA-based drugsSmall molecule
- Industry
- Contract Research Organization
02
Partnerships
Life Science Nation / RESI Conference Series sponsor/alliance partnerBioGeometry (AI-driven large molecule drug design collaboration)CDMO partnerships with multiple state-of-the-art Chinese manufacturers for tech transfer/commercial production
Beyond the preview
Go deeper on BioMetas.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioMetas.